Government praised over move to decriminalise drug addicts



KUALA LUMPUR, June 24 (Bernama) -- The Federation of Private Medical Associations Malaysia (FPMPAM) and the Addiction Medicine Associations of Malaysia (AMAM) have applauded the government for its decision over the decriminalisation of drug addicts.

Dr Steven KW Chow, the president of both associations, noted that the medical fraternity had long appealed for a compassionate approach to the management of those afflicted by drug addiction and advocated for the important role of medication assisted theraphy (MAT) together with psychosocial intervention at all levels of the community.

“We fully support this policy decision and will offer our services and resources to the government to help curb the ever rising danger of addiction," he said in a statement.

Dr Chow said the scientific evidence of addiction as a chronic brain disorder was irrefutable.

He further said that amendments to relevant provisions in the Drug Dependants (Treatment and Rehabilitation) Act 1983 would enable those in addiction to legally and confidently seek medical treatment.

Earlier today, Bernama reported that drug addicts in this country were no longer seen as criminals who must be punished but were patients in need of treatment and rehabilitation.

This follows a discussion between the Home Ministry and the Health Ministry in Putrajaya which concurred on the need to decriminalise drug addicts.

-- BERNAMA 

 

 

 


 






HealthEdge


EXCLUSIVE

Vivantis Technologies Elevates COVID-19 Testing Capacity In Malaysia

By Nadia Jumri

KUALA LUMPUR (Bernama) – The world has been battling COVID-19 for close to a year now, with more than 200 countries and territories affected by the pandemic.

In Malaysia, the third wave of infections led to total case numbers spiking to over 75,000. Globally, the virus has infected more than 68 million people and caused over 1.5 million fatalities.

Due to the virus’ highly virulent nature, producing COVID-19 test kits has become a top priority for certain biotechnology companies focusing on research and development (R&D) in Malaysia.

read more ››

IN FOCUS

Pandangan rakyat Malaysia tentang peningkatan sasaran pemberian vaksin COVID-19 kepada 70 peratus.


UMSC: Pain Management

In Focus : UMSC Raya Open House 2018

In Focus: UMSC Consultant Speaks Erectile Dysfunction Precursor For Heart Disease Part 2

In Focus: UMSC Consultant Speaks Erectile Dysfunction Precursor For Heart Disease Part 1